P

Profluent

AI-designed bespoke proteins for genetic therapies

Computational Research Intern

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
InternshipEmeryville, CA, USANo salary listed

About the Job

Requirements

  • Be a current master's or PhD student or a recent graduate in Bioinformatics, Computational Biology, Machine Learning, Computer Science, Statistics, or a related quantitative field.
  • Have strong programming skills in Python and familiarity with scientific computing libraries such as NumPy, pandas, and Jupyter.
  • Have experience in one or more of machine learning, large-scale data analysis, genomics, or protein bioinformatics.

Responsibilities

  • Design and implement computational approaches to advance research in bioinformatics and machine learning.
  • Analyze large-scale genomic and protein datasets to uncover biological insights and capabilities.
  • Collaborate with scientists and engineers across machine learning, protein engineering, and biology teams.
  • Document and present research findings internally, with the potential to publish in leading journals and conferences.

About the Company

Profluent

AI-designed bespoke proteins for genetic therapies

Profluent.bio designs custom proteins for genetic medicines using artificial intelligence. Its core offering is bespoke protein solutions tailored to therapeutic needs for pharmaceutical and biotech partners, helping advance treatments for genetic diseases. The product works by applying AI to optimize protein design, effectively decoding the “language of life” to create proteins that extend beyond natural or existing patented options. Partners collaborate on projects, with revenue coming from upfront fees, milestones, and royalties on successful commercialization of therapies that use their proteins. The company differentiates itself by combining AI-driven protein design with a partnership model in the gene editing and synthetic biology space, aiming to deliver more effective and precise treatments while enabling cost-efficient development. The goal is to accelerate genetic medicine by providing optimized proteins that enable new or improved therapies for genetic diseases.

Company size
51-200
Company stage
Late Stage VC
Total funding
$149M
Headquarters
Emeryville, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Profluent

See more jobs